Myriad Genetics, Inc.MYGNNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | -1.50% |
| Q3 2025 | -4.56% |
| Q2 2025 | -45.60% |
| Q1 2025 | 0.21% |
| Q4 2024 | -4.39% |
| Q3 2024 | -1.51% |
| Q2 2024 | -3.32% |
| Q1 2024 | -7.06% |
| Q4 2023 | 8.79% |
| Q3 2023 | -7.08% |
| Q2 2023 | -12.40% |
| Q1 2023 | -5.48% |
| Q4 2022 | -4.31% |
| Q3 2022 | -6.09% |
| Q2 2022 | 0.37% |
| Q1 2022 | -5.19% |
| Q4 2021 | 3.41% |
| Q3 2021 | 5.15% |
| Q2 2021 | 1.45% |
| Q1 2021 | -2.11% |
| Q4 2020 | -3.31% |
| Q3 2020 | -1.10% |
| Q2 2020 | -5.42% |
| Q1 2020 | -10.13% |
| Q4 2019 | -0.68% |
| Q3 2019 | -1.72% |
| Q2 2019 | 0.53% |
| Q1 2019 | 2.90% |
| Q4 2018 | -8.92% |
| Q3 2018 | 14.39% |
| Q2 2018 | 1.30% |
| Q1 2018 | 3.00% |
| Q4 2017 | 3.95% |
| Q3 2017 | 11.28% |
| Q2 2017 | 3.85% |
| Q1 2017 | 2.22% |
| Q4 2016 | 0.52% |
| Q3 2016 | 0.00% |
| Q2 2016 | -1.62% |
| Q1 2016 | -0.64% |